该词条未找到_海词词典

您要查找的是不是：

Such massive splenomegaly is usually indicative of some myeloproliferative disease such as chronic myelogenous leukemia or myelofibrosis. 这样的脾肿大通常预示有骨髓增生型疾病，例如慢性髓性白血病或骨髓纤维化。
CNL was a rare clinicopathologic entity that could distinguished from chronic myelogenous leukemia. CNL是一种少见类型的慢性白血病 ,其特点与慢性髓细胞白血病不同 ;
The BCR/ABL fusion gene plays an important role in the malignant transformation of chronic myelogenous leukemia (CML). 融合基因 BCR/ABL在慢性粒细胞白血病的恶性转化过程中起着主导作用 .
It is approved for the treatment of chronic myelogenous leukemia (CML) and hairy cell leukemia. 它被批准用于慢性髓细胞白血病和毛细胞白血病的治疗。
No bcr/abl gene was revealed in the controls, while in the chronic myelogenous leukemia(CML) group the positive rate was 89.5%(17/19). 对照组bcr/abl基因表达均为阴性。慢性粒细胞白血病 (CML)病人bcr/abl基因表达阳性率为 89.;5%25 (1 7/ 1 9);经治疗达临床缓解者 8例;bcr/abl基因表达均值为 (2
The bcr/abl gene has been documented as having a significant role to play in the pathogenesis of Ph+ chronic myelogenous leukemia (CML). Ph~+慢性粒细胞白血病(CML)的bcr/abl融合基因在其发病机制中具有重要作用。
Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disease of transformed hematopoietic progenitor cells. 慢性粒细胞白血病(chronic myelogcnous leukemia,CML)是一种以髓系细胞受累为主的多能造血干细胞的克隆性疾病。
Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder due to an acquired abnormality in a pluripotential hematopoietic stem cell. 慢性粒细胞白血病(Chronic Myelogenous Leukemia，CML，简称慢粒)是一种起源于多能干细胞异常克隆的恶性增殖性疾病。
Objective To investigate the relationship between cyclin D2 and P210 BCR/ABL tyrosine kinase in chronic myelogenous leukemia(CML). 目的研究cyclinD2基因表达与慢性粒细胞白血病 (CML)特征性的P2 10 BCR ABL蛋白酪氨酸激酶活性之间的相关性。
The combination regimen of HHT and Ara c is effective and economical in patient with late chronic-phase chronic myelogenous leukemia(CML). 高三尖杉酯碱联合低剂量阿糖胞苷治疗慢粒白血病急变简便 ,经济 ,有效
Title： Proliferation of reticulin fibre and megakaryocyte in bone marr ow of Guangix,patients with chronic myelogenous leukemia. 关键词：慢性白血病；骨髓纤维化；网硬蛋白纤维；巨核细胞；骨髓活组织检查
Method:Using RT PCR technique,the change of bcr/abl genes in chronic myelogenous leukemia (CML) and polycythemia vera (PV) were investigated. 方法：采用逆转录多聚酶链反应（RT－PCR）技术，研究了慢性粒细胞白血病（CML）、真性红细胞增多症（PV）bcr/abl基因的变化。
Leukemia is a type of cancer. There are 4 main types of leukemia. Chronic myelogenous leukemia ( CML ) is 1 of the 4 types. 白血病是一种恶性肿瘤，主要分为四种。慢粒(CML)是其中之一。
The GVM effect underlying the non-myeloablative transplant procedure is strongest in patients being treated for chronic myelogenous leukemia (CML). 在非清髓干细胞移植操作中，慢性髓细胞白血病患者的GVM效应最为强烈。
Objective:To investigate the value of the detection of Ph chromosome and bcr/abl fusion gene in the diagnosis? treatment and prognosis in chronic myelogenous leukemia (CML). 目的 :观察 Ph染色体、bcr/ abl融合基因与慢性粒细胞白血病 (CML)诊断、疗效、预后的关系。
Objective:To study on relationship between of BCR/ABL fusion gene expression and TCM syndrome classification in the patient of chronic myelogenous leukemia(CML). 目的:探讨慢性粒细胞白血病(CML)患者BCR/ABL融合基因表达与中医辨证分型的关系。
Objective:To study the level of bcr/abl fusion gene expression in the diagnosis,treatment and prognosis in chronic myelogenous leukemia(CML)and primary myelofibrosis(MF). 目的探讨bcr/abl融合基因的表达水平在慢性粒细胞白血病(CML)和原发性骨髓纤维化(MF)患者的诊断、疗效及预后观察中的意义。
In 70s, it had been confirmed that HHT had favorably therapeutic activity in patients with acute myelogenous leukemia (AML) and chronic myelogenous leukemia (CML). 我国在70年代将其用于急性非淋巴细胞白血病(AML)和慢性粒细胞白血病(CML)的治疗取得良好疗效。
The drug Gleevec, for example, was designed to inhibit an enzyme produced by a mutant fused version of two genes, called BCR-ABL, that causes chronic myelogenous leukemia. 以基利克（Gleevec）这个药物为例。基利克的设计是用来抑制某个造成慢性骨髓性白血症的酵素活性；该酵素是由BCR-ABL这两个基因混合而成的突变版本所生成。
Objective: To study the effect of meisoindigo on human chronic myelogenous leukemia (CML) cell line K562 cells for exploring the mechanism of meisoindigo in treatment of CML. 目的：研究甲异靛对人慢性粒细胞白血病细胞系K562细胞的影响，探讨甲异靛治疗慢性粒细胞白血病(CML)的作用机理。